Clopidogrel, a thienopyridine P2Y12 inhibitor of platelet function, is a cornerstone of cardiovascular pharmacotherapy, with aspirin, in the prevention of myocardial infarction (MI) and stent thrombosis after acute coronary syndromes and percutaneous coronary intervention (PCI). The gene discussed is P2RY12; the disease is myocardial infarction.